HomeInvestors HealthDisc Medicine stock rallies 26% on FDA update for bitopertin (NASDAQ:IRON) Disc Medicine stock rallies 26% on FDA update for bitopertin (NASDAQ:IRON) By BOMAR ENT. November 4, 2024 FacebookTwitterPinterestWhatsApp JHVEPhoto Disc Medicine (NASDAQ:IRON) stock soared 26% Monday after the company said there was a potential to apply for FDA accelerated approval of its drug bitopertin for the treatment of erythropoietic protoporphyria, or EPP, based on existing data. Disc (IRON Source link Previous articleOPTIONS TRADING: A Beginners Crash Course [8 BOOKS in 1] | Including Trading Journal Log Book for Stock Trading and InvestingNext articleToday in history: Financial Insight finance #newspaper #history #history #ai #today latest articles explore more Modern Trading Strategies 2025: A Beginner’s Guide to Profitable Markets: Learn Stocks, Options, Forex & Futures with AI-Powered and Proven Methods Options Trading Crash Course: The Complete Crash Course to Avoid Beginner Mistakes in Options Trading and Master Covered Call Trading and Trading Strategies to... 5 Years Later, He Owns 17 Properties Mastering the 20 EMA: From Minutes to Months: 20 EMA Strategies for Scalping, Day Trading, Swing Trades, and Investing Best Growth Stocks to Buy for May 22nd – May 21, 2026 Start. Scale. Exit. Repeat.: Serial Entrepreneurs’ Secrets Revealed! LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
